In MDS, Tet2 mutation not only causes DNA methylation but also results in the dysregulation of gene expression in hematopoietic stem/progenitor cells (HSPCs) as well as the specific proliferation of abnormal myeloid cells (Lin et al., 2014). The gene discussed is TET2; the disease is myelodysplastic syndrome.